Results

Total Results: 579 records

Showing results for "Grade D Cancer".

  1. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/improved-cancer-outcomes-protocol_0.pdf
    December 01, 2021 - characteristics, including age at diagnosis, tumor type, stage of disease, type of cancer treatment … (such as Head and Neck, Breast, Multiple Cancers, etc.) and report the intervention comparisons and … Walsh D, Szafranski M, Aktas A, Kadakia KC. … emia* or melanoma* or myeloma* or neoplasm* or radiotherap* or radiation therap*).ti,ab. … or exp Neoplasms/ or chemoprevention/ or chemoradiotherapy/ or chemoradiotherapy, adjuvant/ or chemotherapy
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-radiation_technical-brief.pdf
    November 01, 2009 - (e.g., lung, prostate, breast) and uncommon cancers (e.g., skull base tumors, uveal melanomas). … cancer) • Head and neck cancers, including malignancies of the brain (e.g., glioblastoma); of the … the sclera for some ocular cancers or in the uterus for some gynecologic malignancies), or may be directly … ), and cancers of the head and neck (brain tumors, and tumors arising from skull base, cervical spine … Treated cancers included malignant tumors in the head, neck and spine, non- small cell lung cancer, prostate
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
    September 18, 2012 - d. What AEs are associated with these vaccines in the fetus/infant? 1. … D. … United States Cancer Statistics: 1999–2008 Incidence and Mortality Data. … Ball R, Horne D, Izurieta H,et al. … Owens DK, Lohr KN, Atkins D, et al.
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/undescended-testicle_research-protocol.pdf
    September 02, 2011 - An estimated 10 percent of all testicular tumors develop from an undescended testis, 9 and the relative … risk of incidence of a testicular tumor is about 40 times greater in men with cryptorchidism when … Testicular malignancy and cancer 9. Hernia 10. … D. … Wells G, Shea B, O’Connell D, et al.
  5. effectivehealthcare.ahrq.gov/products/undescended-testicle/research-protocol
    September 02, 2011 - An estimated 10 percent of all testicular tumors develop from an undescended testis, 9 and the relative … risk of incidence of a testicular tumor is about 40 times greater in men with cryptorchidism when compared … D. … Each key outcome on each comparison of interest will be given an overall evidence grade based on the … Wells G, Shea B, O’Connell D, et al.
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
    November 12, 2013 - For example, choosing to remove or destroy a low-grade prostatic malignancy can lead to complications … D. … Saslow D, Solomon D, Lawson HW, et al. … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR precancerous OR hypertrophy … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR precancerous)) Filters:Publication
  7. S123 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
    October 01, 2007 - stage, grade and tumor location, age, payer, comorbidities, patients distance to nearest hospital, and … Differences re- mained in the distributions of age and tumor grade across patients grouped by the instruments … Iowa Cancer Registry officials suggested that grade distribution differences re- flected different reporting … sizes (�2, 2–5, and 5� cm), positive lymph node involvement, tumor grade groups (1, 2, 3, 4, 9-unknown … sizes (�2, 2–5, and 5� cm), positive lymph node involvement, tumor grade groups (1, 2, 3, 4, 9-unknown
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
    April 01, 2021 - GRADE Working Group. 2013. 3. … Snyder D, Sullivan N, Margolis D, et al. Skin substitutes for treating chronic wounds. … Writing Committee of the Breast Cancer Working Group, Cancer Intervention and Surveillance Modeling … sensitivity, specificity, positive and negative predictive values) in screening for gynecological cancersD-1 Appendix D. Review of Technical Briefs Table D-1.
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_executive.pdf
    February 01, 2012 - is one of the most common malignancies of women, with approximately 200,000 new cases diagnosed … The grade was developed by considering four important domains: the risk of bias in the evidence base … Breast Cancer. 2001;8(2):116-24. PMID: 11342984 47. Torheim G, Godtliebsen F, Axelson D, et al. … Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison … D galactose-based signal-enhanced color Doppler sonography of breast tumors and tumorlike lesions.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_executive.pdf
    February 01, 2014 - Cervical cancer (insufficient data to estimate incidence) Low The risk of cervical cancer did not differ … reported on cervical cancer. … All cancers (insufficient data to estimate incidence) Low The risk of nonmelanoma skin cancer was higher … All cancers (insufficient data to estimate incidence) Low The risk of nonmelanoma skin cancer was higher … All cancers (insufficient data to estimate incidence) Low The risk of other cancers did not differ
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-studies_white-paper.pdf
    December 01, 2013 - Norris S, Atkins D. … Chou R, Aronson N, Atkins D, et al. … The GRADE Working Group. GRADE guidelines: 9. Rating up the quality of evidence. … Norris S, Atkins D, Bruening W, et al. … Chou R, Hartung D, Rahman B, Wasson N, Cottrell E, Fu R.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
    September 18, 2012 - d. What AEs are associated with these vaccines in the fetus/infant? 1. … D. … United States Cancer Statistics: 1999–2008 Incidence and Mortality Data. … Ball R, Horne D, Izurieta H,et al. … Owens DK, Lohr KN, Atkins D, et al.
  13. effectivehealthcare.ahrq.gov/products/cancer-pancreas/research-protocol
    August 09, 2013 - Diagnostic management of pancreatic cancer. Cancers. 2011 Mar;3(1):494-509. … Moher D, Pham B, Klassen TP, et al. … / or exp pancreas, exocrine/) and (neoplasm/ or adenocarcinoma/ or neoplasms/)) or pancreas tumor … r$ or sarcoma$ or neoplasm$ or carcinoma$ or adenocarcinoma$)).mp. 4   neuroendocrine tumors … and imaging and diagnosis 17 and 23 25 Staging Cancer staging/ or Neoplasm staging/ 26  
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_disposition-comments.pdf
    December 11, 2012 - PFS where presented is in the appendix D. … This will not impact the overall GRADE conclusions. … Size and number of tumors is not relevant for stratifying embolotherapy patients; instead, % tumor … We have added these to appendix D. … In contrast, image-guided therapies treat tumors piecemeal.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/people-with-disabilities-protocol.pdf
    January 16, 2024 - A and Grade B recommendations: - Screening (anxiety disorders, breast cancer, cervical cancer, colorectal … Each included preventive service has a Grade A or Grade B recommendation from the United States Preventive … Wells M, Turner S, Martin D, et al. … Atkins D, Chang SM, Gartlehner G, et al. … Because having a USPSTF Grade A or Grade B recommendation is an inclusion criterion for the systematic
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper.pdf
    September 01, 2015 - Atkins D, Siegel J, Slutsky J. Making policy when the evidence is in dispute. … Owens DK, Lohr KN, Atkins D, et al. … Lemiengre MB, van Driel ML, Merenstein D, et al. … Trastuzumab containing regimens for early breast cancer. … Schunemann HJ, Best D, Vist G, et al.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea-protocol-amended.pdf
    May 19, 2020 - Supplemental oxygen therapy (for hypoxemic and non-hypoxemic patients) d. … Respiratory training d. Pulmonary rehabilitation e. Chest wall vibration f. … Reiki d. Mindfulness e. Yoga f. Meditation g. … Strength of Evidence (SOE) for Major Comparisons and Outcomes: At the completion of our review, we will grade … a key outcome includes both RCTs and other intervention studies with a comparison group, we will grade
  18. effectivehealthcare.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
    September 01, 2020 - Effects may not vary by patient or tumor factors. … one of the most frequently diagnosed cancers among U.S. men (191,930 new cases) and the second leading … cause of cancer death (33,330).1 In 90 percent of newly diagnosed cancers, the disease is confined … We modified AHRQ methods for this review by using GRADE and EPC tools for risk of bias and certainty … Higgins JPT, Altman D, Sterne J. Chapter 8: Assessing risk of bias in included studies.
  19. effectivehealthcare.ahrq.gov/products/uterine-fibroids/research-protocol
    February 29, 2016 - background Most women will develop one or more uterine fibroids (i.e., leiomyomata), benign smooth muscle tumors … among those with symptoms in part due to earlier age at onset of fibroids with larger and more numerous tumors … address the potential harms associated with morcellation, as well as an exploration of patient and tumor … Zimmermann A, Bernuit D, Gerlinger C, et al. … Shamseer L, Moher D, Clarke M, et al.
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-antigen-3-gene_research.pdf
    April 01, 2013 - The prostate cancer antigen-3 gene (PCA3) has recently been found to be overexpressed in prostate cancers … : 3 2012 ASCO Conference Abstracts D-1 Appendix D. … Table D.1. … Table D.2. … D-3 25. Schilling D, Hennenlotter J, Munz M, et al.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: